Angiosarcoma of the larynx is a rare tumor that can be differentiated from pseudo-angiosarcomatous carcinoma using specific immunohistochemical markers.
Answers are grounded in this paper and cite their sources.
Supports IHC differentiation of laryngeal angiosarcoma from carcinoma in rare cases; leaves open validation in larger series.
The morphological and immunohistochemical features of a laryngeal angiosarcoma are described. Initially, the tumour was interpreted as a poorly differentiated squamous cell carcinoma. The laryngectomy specimen contained an extensive and haemorrhagic tumour consisting of irregular and dissecting vascular spaces delineated by pleomorphic endothelial cells. In addition to these obvious angiosarcomatous areas, islands of more compact growing tumour cells were present, reminiscent of a poorly differentiated squamous cell carcinoma. On immunohistochemistry, the tumour cells expressed factor VIII, Ulex europaeus I lectin, CD31 and vimentin. There was no expression of cytokeratin or epithelial membrane antigen. Angiosarcoma of the larynx is very rare and should be differentiated from a pseudo-angiosarcomatous carcinoma.
No takes yet. Share an insight, caveat, or question.
Sciot et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: